These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
450 related articles for article (PubMed ID: 9258630)
1. Drug administration in chronic liver disease. Westphal JF; Brogard JM Drug Saf; 1997 Jul; 17(1):47-73. PubMed ID: 9258630 [TBL] [Abstract][Full Text] [Related]
2. An intensive drug monitoring study suggesting possible clinical irrelevance of impaired drug disposition in liver disease. Naranjo CA; Busto U; Janecek E; Ruiz I; Roach CA; Kaplan K Br J Clin Pharmacol; 1983 Apr; 15(4):451-8. PubMed ID: 6849781 [TBL] [Abstract][Full Text] [Related]
3. Drug administration in patients with renal insufficiency. Minimising renal and extrarenal toxicity. Matzke GR; Frye RF Drug Saf; 1997 Mar; 16(3):205-31. PubMed ID: 9098657 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. Verbeeck RK Eur J Clin Pharmacol; 2008 Dec; 64(12):1147-61. PubMed ID: 18762933 [TBL] [Abstract][Full Text] [Related]
5. Analgesics in patients with hepatic impairment: pharmacology and clinical implications. Bosilkovska M; Walder B; Besson M; Daali Y; Desmeules J Drugs; 2012 Aug; 72(12):1645-69. PubMed ID: 22867045 [TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacokinetics of newer antibacterial agents in liver disease. Westphal JF; Brogard JM Clin Pharmacokinet; 1993 Jan; 24(1):46-58. PubMed ID: 8448972 [TBL] [Abstract][Full Text] [Related]
7. Dose adjustment in patients with liver disease. Delcò F; Tchambaz L; Schlienger R; Drewe J; Krähenbühl S Drug Saf; 2005; 28(6):529-45. PubMed ID: 15924505 [TBL] [Abstract][Full Text] [Related]
8. Effect of hepatic insufficiency on pharmacokinetics and drug dosing. Verbeeck RK; Horsmans Y Pharm World Sci; 1998 Oct; 20(5):183-92. PubMed ID: 9820880 [TBL] [Abstract][Full Text] [Related]
9. [Safe prescribing in patients with liver cirrhosis; 5 pitfalls]. Weersink RA; Drenth JPH; Ter Borg F; Mulder MB; Taxis K; Borgsteede SD Ned Tijdschr Geneeskd; 2020 Oct; 164():. PubMed ID: 33201633 [TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacokinetics of angiotensin converting enzyme (ACE) inhibitors in renal failure. Hoyer J; Schulte KL; Lenz T Clin Pharmacokinet; 1993 Mar; 24(3):230-54. PubMed ID: 8462229 [TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. An update. Morgan DJ; McLean AJ Clin Pharmacokinet; 1995 Nov; 29(5):370-91. PubMed ID: 8582120 [TBL] [Abstract][Full Text] [Related]
12. Lopinavir/ritonavir: a review of its use in the management of HIV infection. Cvetkovic RS; Goa KL Drugs; 2003; 63(8):769-802. PubMed ID: 12662125 [TBL] [Abstract][Full Text] [Related]
13. Prescribing medications in patients with decompensated liver cirrhosis. Amarapurkar DN Int J Hepatol; 2011; 2011():519526. PubMed ID: 21994861 [TBL] [Abstract][Full Text] [Related]
14. Mechanistic basis of adverse drug reactions: the perils of inappropriate dose schedules. Shah RR Expert Opin Drug Saf; 2005 Jan; 4(1):103-28. PubMed ID: 15709902 [TBL] [Abstract][Full Text] [Related]
15. Review article: prescribing medications in patients with cirrhosis - a practical guide. Lewis JH; Stine JG Aliment Pharmacol Ther; 2013 Jun; 37(12):1132-56. PubMed ID: 23638982 [TBL] [Abstract][Full Text] [Related]